Skip to main content

OrbiMed Advisors LLC's Form 4 filing

Disc Medicine, Inc. (IRON) · filed Dec 14, 2023

Accession no.
0000947871-23-001148
Filed
Dec 14, 2023, 5:44 PM ET
Trade date
Dec 12-14, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 8 non-derivative transactions. Open-market sales total $7.90M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
OrbiMed Advisors LLCCIK 0001055951Director
OrbiMed Capital GP VI LLCCIK 0001682115Director
OrbiMed Genesis GP LLCCIK 0001808744Director
OrbiMed Capital GP VIII LLCCIK 0001845804Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 12, 2023Common StockSSaleDisposed−14,400$60.16−$866,3041,182,425IndirectDuplicate filing
Dec 12, 2023Common StockSSaleDisposed−9,300$60.16−$559,488764,307IndirectDuplicate filing
Dec 12, 2023Common StockSSaleDisposed−3,600$60.16−$216,576295,605IndirectDuplicate filing
Dec 13, 2023Common StockSSaleDisposed−56,200$58.56−$3,291,0721,126,225IndirectDuplicate filing
Dec 13, 2023Common StockSSaleDisposed−36,400$58.56−$2,131,584727,907IndirectDuplicate filing
Dec 13, 2023Common StockSSaleDisposed−14,100$58.56−$825,696281,505IndirectDuplicate filing
Dec 14, 2023Common StockSSaleDisposed−100$57.73−$5,7731,126,125IndirectDuplicate filing
Dec 14, 2023Common StockSSaleDisposed−100$57.73−$5,773727,807IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)